News
During a live event, Christopher J. Ferreri, MD, discussed findings on dose and schedule modifications of talquetamab in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback